Delivery Order SPE2DR25D3103-SPE2DR26F9L77
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $73,152.00 to AmerisourceBergen Drug Corp for the supply of Azithromycin 500 mg tablets (30-count units) on September 5, 2025, with an ultimate completion date of September 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Azithromycin 500 mg tablets (30-count units) with a ceiling value of $4,697.79. This is a firm fixed-price, non-set-aside delivery order expected to conclude by October 24, 2025, with performance taking place at the company's headquarters in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's ongoing role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Azithromycin 500 mg tablets in quantities of 30 units under a firm fixed-price contract structure. The award, announced on December 9, 2025, carries a ceiling value of $114,718.18 and includes an ultimate completion date of December 10, 2025. This non-set-aside award was competitively procured and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $6,034.70 to AmerisourceBergen Drug Corp for the supply of Azithromycin 500 mg tablets (30-count units) on November 3, 2025, with an ultimate completion date of November 4, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Azithromycin 250 mg tablets in quantities of 30 units. This contract, valued at $6,100.26, represents a firm fixed price delivery order with an ultimate completion date of August 1, 2025. The award is non-competitive and carries no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform...
- The Defense Logistics Agency (DLA) awarded a $2,604.70 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Azithromycin 500 mg tablets in quantities of 30 units. This contract utilizes a firm fixed price structure with no set-aside designation, indicating it was competitively awarded. The order is scheduled for completion by September 18, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Azithromycin 500 mg tablets in quantities of 30, with a contract ceiling value of $1,430.45. This is a firm fixed-price delivery order under a non-competitive, non-set-aside arrangement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 19, 2025. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Azithromycin 500 mg tablets in quantities of 30 units. This contract, valued at $28,610.20, represents a firm fixed-price delivery order with no set-aside designation, reflecting a competitive award to the prime contractor. The delivery is scheduled for completion by October 22, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Azithromycin 250 mg tablets in quantities of 30 units. This delivery order, valued at $1,255.04 with a firm fixed price structure, represents a non-competitive set-aside award and is scheduled for completion by September 17, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Azithromycin 500 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside delivery order carries a ceiling value of $9,542.76 with firm fixed pricing and is scheduled for completion by October 20, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9L77Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Azithromycin 500 mg tablets (30-count) under a firm fixed-price contract. The award, issued on December 4, 2025, carries a ceiling value of $108,142.25 and is scheduled for completion by December 5, 2025. The contract is non-competitive with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location, leveraging its established position as a critical pharmaceutical distributor for federal medical procurement. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies across multiple therapeutic domains in support of military healthcare systems worldwide. This particular order for azithromycin, a commonly used antibiotic, exemplifies the routine pharmaceutical procurement activities conducted through this expansive federal contract vehicle to support Defense Health Agency operations and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $108.1k | 12/3/25 |